The possibility of cancer immune editing in gliomas. A critical review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The possibility of cancer immune editing in gliomas. A critical review

Published:2018-04-09 Issue:7 Volume:7 Page:e1445458
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Arrieta Víctor A.¹,Cacho-Díaz Bernardo²,Zhao Junfei³,Rabadan Raul³,Chen Li⁴,Sonabend Adam M.⁴

Affiliation:

1. PECEM, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

2. Neuroscience Unit, National Cancer Institute, Mexico City, Mexico

3. Department of Systems Biology, Herbert Irving Comprehensive Center, Columbia University, New York City, New York, USA

4. Department of Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1445458

Reference85 articles.

1. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

2. Mutational landscape and clonal architecture in grade II and III gliomas

3. The Somatic Genomic Landscape of Glioblastoma

4. Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma;Journal of Clinical Investigation;2024-06-17

2. Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium;Cancer Discovery;2024-01-24

3. Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients;Methods in Cell Biology;2023

4. TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy;Cancers;2022-07-12

5. ThPOK inhibits the immune escape of gastric cancer cells by inducing STPG1 to inactivate the ERK pathway;BMC Immunology;2022-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3